Literature DB >> 9607353

Adjuvant radiotherapy for squamous cell carcinoma of the tongue base: improved local-regional disease control compared with surgery alone.

K W Nisi1, R L Foote, J A Bonner, T V McCaffrey.   

Abstract

PURPOSE: The purpose of this retrospective study is to present the results of postoperative adjuvant radiotherapy after primary surgery for squamous cell carcinoma of the tongue base and to compare these results to those obtained with surgery alone.
METHODS: Between 1974 and 1993, continuous-course postoperative radiotherapy was delivered to 24 patients (Adjuvant Radiotherapy Group). Results were compared to those from a group of 55 patients treated with surgery alone (Surgery Group).
RESULTS: Characteristics of the two groups were similar, except that a larger proportion of patients in the Adjuvant Radiotherapy Group had higher pathologic TNM stages. Ipsilateral neck control (87% vs. 68%, p = 0.04), contralateral neck control (100% vs. 76%,p = 0.002), relapse-free survival (64% vs. 46%,p = 0.04), and control above the clavicles (80% vs. 48%, p = 0.007) were significantly higher in the Adjuvant Radiotherapy Group compared to those in the Surgery Group (5-year figures shown).
CONCLUSION: The use of adjuvant radiotherapy after surgical resection of tongue base squamous cell carcinoma significantly decreased the rate of local-regional recurrence and improved relapse-free survival compared with surgery alone but did not alter cause-specific or overall survival.

Entities:  

Mesh:

Year:  1998        PMID: 9607353     DOI: 10.1016/s0360-3016(98)00059-5

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  7 in total

1.  Oncologic and functional results after transoral laser microsurgery of tongue base carcinoma.

Authors:  Martin Canis; Friedrich Ihler; Hendrik A Wolff; Hans Christiansen; Christoph Matthias; Wolfgang Steiner
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-07-05       Impact factor: 2.503

2.  Treatment of base of tongue cancer, stage III and stage IV with primary surgery: survival and functional outcomes.

Authors:  Khaled Al-Qahtani; Jen Rieger; Jeffery R Harris; Alex Mlynarek; David Williams; Tahera Islam; Hadi Seikaly
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-25       Impact factor: 2.503

3.  Is there a patient population with squamous cell carcinoma of the head and neck region who might benefit from de-intensification of postoperative radiotherapy? : A monocentric retrospective analysis of a previously defined low-risk patient population treated with standard-of-care radiotherapy.

Authors:  Yonca Onbasi; Sebastian Lettmaier; Markus Hecht; Sabine Semrau; Heinrich Iro; Marco Kesting; Rainer Fietkau; Marlen Haderlein
Journal:  Strahlenther Onkol       Date:  2019-01-04       Impact factor: 3.621

4.  Treatment of upper aerodigestive tract cancers in England and its effect on survival.

Authors:  D M Edwards; N W Johnson
Journal:  Br J Cancer       Date:  1999-09       Impact factor: 7.640

5.  A novel curcumin analog (H-4073) enhances the therapeutic efficacy of cisplatin treatment in head and neck cancer.

Authors:  Bhavna Kumar; Arti Yadav; Kalman Hideg; Periannan Kuppusamy; Theodoros N Teknos; Pawan Kumar
Journal:  PLoS One       Date:  2014-03-27       Impact factor: 3.240

6.  Pulsed dose rate brachytherapy as the boost in combination with external beam irradiation in base of tongue cancer. Long-term results from a uniform clinical series.

Authors:  Bengt Johansson; Leif Karlsson; Johan Reizenstein; Mathias von Beckerath; Lennart Hardell; Jan Persliden
Journal:  J Contemp Brachytherapy       Date:  2011-03-31

7.  Bazedoxifene enhances the anti-tumor effects of cisplatin and radiation treatment by blocking IL-6 signaling in head and neck cancer.

Authors:  Arti Yadav; Bhavna Kumar; Theodoros N Teknos; Pawan Kumar
Journal:  Oncotarget       Date:  2016-08-22
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.